StockData
Veracyte, Inc. logo

Veracyte, Inc. (VCYT) stock

VCYTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 16/3034% below fair value
$24.23+0.22 (+0.92%)

Close on Nov 17, 2026Market cap $1.95BP/E 17.3Yield –

Veracyte EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Veracyte's EV/EBITDA was 13.6× on Nov 11, 2026, against 72.7× a year earlier.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202613.6×−50.3
2025Dec 31, 202563.9×–

More Veracyte figures

See a number that looks wrong?